Therapeutic implication of L-phenylalanine aggregation mechanism and its modulation by D-phenylalanine in phenylketonuria

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Singh, Virender ^a   Rai, Ratan Kumar ^b   Arora, Ashish ^c   Sinha, Neeraj ^b   Thakur, Ashwani Kumar ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY KANPUR   (India)

^b SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^c CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

PHENYLALANINE;

ARTICLE; CHEMISTRY; HUMAN; KINETICS; METABOLISM; NUCLEAR MAGNETIC RESONANCE; PHENYLKETONURIA; SCANNING ELECTRON MICROSCOPY; STEREOISOMERISM;

HUMANS; KINETICS; MICROSCOPY, ELECTRON, SCANNING; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PHENYLALANINE; PHENYLKETONURIAS; STEREOISOMERISM;

EID: 84893287012     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep03875     Document Type: Article

References (50)

1. Blau, N., van Spronsen, F. J. & Levy, H. L. Phenylketonuria. Lancet 376, 1417-1427 (2010).
2. Williams, R. A.,Mamotte, C. D. & Burnett, J. R. Phenylalanine: an inborn error of phenylalanine metabolism. Clin. Biochem. Rev. 29, 31-41 (2008).
3. Mitchell, J. J., Trakadis, Y. J. & Scriver, C. R. Phenylalanine hydroxylase deficiency. Genet. Med. 13, 697-707 (2011).
4. Kaufman, S. Amodel of human phenylalanine metabolism in normal subjects and in phenylketonuric patients. Proc. Natl. Acad. Sci. U. S. A. 96, 3160-3164 (1999). (Pubitemid 29148861)
5. Adler-Abramovich, L. et al. Phenylalanine assembly into toxic fibrils suggests amyloid etiology in phenylketonuria. Nat. Chem. Biol. 8, 701-706 (2012).
6. Eisenberg, D. & Jucker, M. The amyloid state of proteins in human diseases. Cell 148, 1188-1203 (2012).
7. Stefani, M. Protein misfolding and aggregation: new examples in medicine and biology of the dark side of the protein world. Biochim. Biophys. Acta 1739, 5-25 (2004). (Pubitemid 39647706)
8. Greenwald, J. & Riek, R. Biology of amyloid: structure, function and regulation. Structure 18, 1244-1260 (2010).
9. Hsu, W.-P., Koo, K.-K. & Myerson, A. S. The gel-crystallization of 1- phenylalanine and aspartame from aqueous solutions. Chem. Eng. Commun. 189, 1079-1090 (2002). (Pubitemid 37317266)
10. Olsztynska, S., Dupuy, N., Vrielynck, L. & Komorowska, M. Water evaporation analysis of L-phenylalanine from initial aqueous solutions to powder state by vibrational spectroscopy. Appl. Spectrosc. 60, 1040-1053 (2006). (Pubitemid 44444424)
11. Olsztynska, S. & Komorowska, M. Conformational Changes of L-phenylalanine induced by near infrared radiation. ATR-FTIR studies. Struct. Chem. 23, 1399-1407 (2012).
12. Guo, C., Luo, Y., Zhou, R. & Wei, G. Probing the self-assembly mechanism of diphenylalanine-based peptide nanovesicles and nanotubes. ACS Nano 6, 3907-3918 (2012).
13. Gazit, E. A possible role for pi-stacking in the self-assembly of amyloid fibrils. FASEB J. 16, 77-83 (2002). (Pubitemid 34027953)
14. Levy, M., Garmy, N., Gazit, E. & Fantini, J. The minimal amyloid-forming fragment of the islet amyloid polypeptide is a glycolipid-binding domain. FEBS J. 273, 5724-5735 (2006). (Pubitemid 44915896)
15. Huang, R. et al. NMR characterization of monomeric and oligomeric conformations of human calcitonin and its interaction with EGCG. J. Mol. Biol. 416, 108-120 (2012).
16. Tu, L. H. & Raleigh, D. P. Role of aromatic interactions in amyloid formation by islet amyloid polypeptide. Biochemistry 52, 333-342 (2013).
17. Boyd-kimball, D., Abdul, H. M., Reed, T., Sultana, R. & Butterfield, D. A. Role of phenylalanine 20 in alzheimer?s amyloid b-peptide (1-42)-induced oxidative stress and neurotoxicity. Chem. Res. Toxicol. 17, 1743-1749 (2004). (Pubitemid 39665568)
18. Kar, K., Jayaraman, M., Sahoo, B., Kodali, R. & Wetzel, R. Critical nucleus size for disease-related polyglutamine aggregation is repeat-length dependent. Nat. Struct. Mol. Biol. 18, 328-336 (2011).
19. Chen, S., Berthelier, V., Hamilton, J. B., O'Nuallain, B. & Wetzel, R. Amyloid-like features of polyglutamine aggregates and their assembly kinetics. Biochemistry 41, 7391-7399 (2002). (Pubitemid 34602457)
20. Zhang, S., Marini, D. M., Hwang, W. & Santoso, S. Design of nanostructured biological materials through self-assembly of peptides and proteins. Curr. Opin. Chem. Biol. 6, 865-871 (2002). (Pubitemid 35449349)
21. Griffith, E. C. & Vaida, V. Ionization state of L-phenylalanine at the air-water interface. J. Am. Chem. Soc. 135, 710-716 (2013).
22. Gasymov, O. K. & Glasgow, B. J. ANS fluorescence: potential to augment the identification of the external binding sites of proteins. Biochim. Biophys. Acta 1774, 403-411 (2007). (Pubitemid 46357065)
23. Gabellieri, E. & Strambini, G. B. ANS fluorescence detects widespread perturbations of protein tertiary structure in ice. Biophys. J. 90, 3239-3245 (2006).
24. Lindgren, M., Sorgjerd, K. & Hammarstrom, P. Detection and characterization of aggregates, prefibrillar amyloidogenic oligomers, and protofibrils using fluorescence spectroscopy. Biophys. J. 88, 4200-4212 (2005). (Pubitemid 40991131)
25. Yousefi, R. et al. Investigation on the surface hydrophobicity and aggregation kinetics of human calprotectin in the presence of calcium. J. Biochem. Mol. Biol. 38, 407-413 (2005). (Pubitemid 43034351)
26. Castellino, F. J. & Barker, R. The Effect of guanidinium, carbamoylguanidinium, and guanylguanidinium salts on the solubility of benzoyl-L-tyrosine ethyl ester and acetyltetraglycine ethyl ester in water. Biochemistry 8, 3439-3442 (1969).
27. England, J. L. & Haran, G. Role of solvation effects in protein denaturation: from thermodynamics to single molecules and back. Annu. Rev. Phys. Chem. 62, 257-277 (2011).
28. Bonechi, C., Martini, S., Magnani, A. & Rossi, C. Stacking interaction study of trans-resveratrol (trans-3,5,49-trihydroxystilbene) in solution by nuclear magnetic resonance and fourier transform infrared spectroscopy. Magn. Reson. Chem. 46, 625-629 (2008).
29. Soong, R., Brender, J. R., MacDonald, P. M. & Ramamoorthy, A. Association of highly compact type II diabetes related islet amyloid polypeptide intermediate species at physiological temperature revealed by diffusion NMR spectroscopy. J. Am. Chem. Soc. 131, 7079-7085 (2008).
30. Cohen, Y., Avram, L. & Frish, L. Diffusion NMR spectroscopy in supramolecular and combinatorial chemistry: an old parameter-new insights. Angew. Chem. Int. Ed. 44, 520-554 (2005). (Pubitemid 40192558)
31. Macchioni, A., Ciancaleoni, G., Zuccaccia, C. & Zuccaccia, D. Determining accurate molecular sizes in solution through NMR diffusion spectroscopy. Chem. Soc. Rev. 37, 479-489 (2008).
32. Mansfield, S. L., Jayawickrama,D. A., Timmons, J. S. & Larive, C. K. Measurement of peptide aggregation with pulsed-field gradient nuclear magnetic resonance spectroscopy. Biochim. Biophys. Acta 1382, 257-265 (1998). (Pubitemid 28130397)
33. Schellman, J. A. Temperature, stability, and the hydrophobic interaction. Biophys. J. 73, 2960-2964 (1997). (Pubitemid 27525762)
34. Chandler, D. Interfaces and the driving force of hydrophobic assembly. Nature 437, 640-647 (2005). (Pubitemid 41486526)
35. Castelletto, V.,Hamley, I. W., Cenker, C. & Olsson,U. Influence of salt on the selfassembly of two model amyloid heptapeptides. J. Phys. Chem. B 114, 8002-8008 (2010).
36. Hu, Y. et al.Dye Adsorption by resins: Effect of ionic strength on hydrophobic and electrostatic interactions. Chem. Eng. J. 228, 392-397 (2013).
37. Sievers, S. A. et al. Structure-based design of non-natural amino-acid inhibitors of amyloid fibril formation. Nature 475, 96-100 (2011).
38. Hochbaum, A. I. et al. Inhibitory effects of D-amino acids on Staphylococcus aureus biofilm development. J. Bacteriol. 193, 5616-5622 (2011).
39. Cegelski, L. et al. Small-molecule inhibitors target Escherichia coli amyloid biogenesis and biofilm formation. Nat. Chem. Biol. 5, 913-919 (2009).
40. Sanna, C. et al. New class of aggregates in aqueous solution: An NMR, thermodynamic, and dynamic light scattering study. Langmuir 22, 6031-6041 (2006). (Pubitemid 44140297)
41. Suzuki, Y., Brender, J. R., Hartman, K., Ramamoorthy, A. & Marsh, E. N. Alternative pathways of human islet amyloid polypeptide aggregation distinguished by (19)f nuclear magnetic resonance-detected kinetics of monomer consumption. Biochemistry 51, 8154-8162 (2012).
42. Marchesan, S. et al. Unzipping the role of chirality in nanoscale self-assembly of tripeptide hydrogels. Nanoscale 4, 6752-6760 (2012).
43. Zhu, X., Li, Y., Duan, P. & Liu, M. Self-assembled ultralong chiral nanotubes and tuning of their chirality through the mixing of enantiomeric components. Chemistry 16, 8034-8040 (2010).
44. Cheng, B., Gong, H., Xiao, H., Petersen, R. B., Zheng, L. & Huang, K. Inhibiting toxic aggregation of amyloidogenic proteins: A therapeutic strategy for protein misfolding diseases. Biochim. Biophys. Acta 1830, 4860-4871 (2013).
45. Yanagida, O. et al. Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines. Biochim. Biophys. Acta 1514, 291-302 (2001). (Pubitemid 32831016)
46. Van Spronsen, F. J., de Groot, M. J., Hoeksma, M., Reijngoud, D. & van Rijn, M. Large neutral amino acids in the treatment of PKU: from theory to practice. J. Inherit. Metab. Dis. 33, 671-676 (2010).
47. Ramamoorthy, A. & Lim, M.H. Structural characterization and inhibition of toxic amyloid-beta oligomeric intermediates. Biophys. J. 105, 287-288 (2013).
48. Braymer, J. et al. Development of bifunctional stillbene derivatives for targeting and modulating metal-amyloid-beta species. Inorg. Chem. 50, 10724-10734 (2011).
49. Detoma, A. S., Salamekh, S., Ramamoorthy, A. & Lim, M.H. Misfolded proteins in alzheimer?s disease and type II diabetes. Chem. Soc. Rev. 41, 608-621 (2012).
50. Wu, D. H., Chen, A. D. & Johnson, C. S. An improved diffusion-ordered spectroscopy experiment incorporating bipolar-gradient pulses. J. Magn. Reson. Series A 115, 260-264 (1995).